A study of the factors inducing the development of childhood-onset myasthenia gravis using CDR3 spectratyping analysis of the TCR repertoire

Journal of Neuroimmunology

Volumn 187, Issue 1-2, 2007, Pages 192-200

  Dokai, Hidenori ^a   Nomura, Yoshiko ^b   Fujikawa, Yoshinao ^a   Nihei, Koichi ^a   Segawa, Masaya ^b   Shinomiya, Noriaki ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^b Segawa Neurological Clinic for Children   (Japan)

Author keywords

CDR3 spectratyping; Childhood onset MG; HLA DR DQ allele haplotype; Superantigen; TCR V repertoire

Indexed keywords

SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOLESCENT; ANALYTIC METHOD; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INFANT; LONGITUDINAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RELAPSE; REMISSION;

CHILD; CHILD, PRESCHOOL; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MYASTHENIA GRAVIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPECTRUM ANALYSIS; T-LYMPHOCYTES;

EID: 34347207187     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.04.021     Document Type: Article

References (29)

1. Ahiberg R., Yi Q., Perskanen R., Matell G., Swerup C., Rieber E.P., Riethmuller G., Holm G., and Lefvert A.K. Treatment of myasthenia gravis with anti-CD4 antibody: correlates to decreased T-cell autoreactivity. Neurology 44 (1994) 1732-1737
2. Andrews P.I., Massey J.M., and Sanders D.B. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology 43 (1993) 977-982
3. Choi Y., Kotzin B., Herron L., Callaham J., Marrack P., and Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 9841-9845
4. Conti-Fine, M.B., Bellone M., Howard Jr, J.F., Protti, M.P., 1997 Myasthenia Gravis. The Immunology of an autoimmune disease. Neuroscience Intelligence Unit. Landes, R.G., Austin, TX, USA pp1-230.
5. Conti-Fine M.B., Navaneetham D., Karachunski P., Raju R., Diethem-Okita B., Okita K., Howard Jr. J., and Wang Z.-Y. T-cell recognition of the acetylcholine receptor in myasthenia gravis. Ann. N.Y. Acad. Sci. 841 (1998) 283-308
6. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330 (1994) 1794-1810
7. Hohlfeld R., and Wekerle H. The thymus in myasthenia gravis. Neurol. Clin. N. Am. 12 (1994) 331-342
8. Igata A. Diagnostic criteria for myasthenia gravis. In: Igata A. (Ed). Proceeding of Neuroimmunological Disorder (1986), Ministry of Health and Welfare of Japan, Tokyo 1-4
9. Infante A.J., Baillargeon J., Kraig E., Lott L., Jackson C., Hammerling G.J., Raju R., and David C. Evidence of a diverse T cell receptor repertoire for acetylcholine receptor, the autoantigen of myasthenia gravis. J. Autoimmun. 21 (2003) 167-174
10. Jaretzki III A., Barohn R.J., Emstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., and Sanders B.D. Myasthenia gravis: recommendations for clinical research standards. Neurology 55 (2000) 16-23
11. Kanai T., Nomura Y., Segawa M., Takaji K., Senjyu S., Matsushita S., and Nishimura Y. Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit peptide presented by the disease susceptible HLA-DQ 6 in infant-onset myasthenia gravis. Hum. Immunol. 56 (1997) 28-38
12. Keesey C.J. Electrodiagnostic approach to defects of neuromuscular transmission. Muscle Nerve 12 (1989) 613-623
13. Kim K.S., Jacob N., and Stohl W. In vitro and in vivo T cell oligoclonality following chronic stimulation with staphylococcal superantigen. Clin. Immunol. 108 (2003) 182-189
14. + population. Immunology 94 (1998) 529-535
15. Matuski K., Juji T., Tokunaga K., Takamizawa M., Maeda H., Soda M., Nomura Y., and Segawa M. HLA antigens in Japanese patients with myasthenia gravis. J. Clin. Invest. 86 (1990) 392-399
16. Matsumoto Y., Yoon W.K., Jee Y., Fujihara K., Mitu T., Sato S., Nakashima I., and Itoyama Y. Complementarity-determining region 3 spectratyping analysis of the T cell repertoire in multiple sclerosis. J. Immunol. 170 (2003) 4846-4853
17. Matsumoto Y.H., Matsuo H.H., Sakuma H., Park II K.Y., Tsukada Y., Kohyama K., Kondo T., Kotorii S., and Shibuya N. CDR3 spectratyping analysis of the TCR repertoire in myasthenia gravis. J. Immunol. 176 (2006) 5100-5107
18. Navarretee C., and Bottazzo F.G. In search of TCR restriction in autoreactive T cell in human autoimmunity: why is it so elusive?. Clin. Exp. Immunol. 91 (1993) 189-192
19. Navaneetham D., Penn A.S., Howaard Jr. J.F., and Conti-Fine B.M. TCR-Vb usage in the thymus and blood of myasthenia gravis patients. J. Autoimmun. 11 (1998) 621-633
20. + T-cell subsets in autoimmunity. Curr. Opin. Immunol. 9 (1997) 872-883
21. Protti M.P., Manfredi A.A., Horton R.M., Bellone M., and Conti-Tronconi B.M. Myasthenia gravis: recognition of an autoantigen at the molecular level. Immunol. Today 14 (1993) 363-368
22. + T cells in myasthenia gravis. J. Autoimmun. 10 (1997) 203-217
23. Segawa M. Myasthenia gravis-latent general type. Naika 31 (1973) 1222-1226
24. Shinomiya N., Aoki T., Nomura Y., and Segawa M. The correlation between the number of TH1-like clones and the clinical signs in childhood-onset myasthenia gravis. Jpn. J. Clin. Immunol. 16 (1993) 272-279
25. Shinomiya N., Shinomiya M., Nomura Y., and Segawa M. Analysis of HLA-DPB1 allele associated with childhood-onset myasthenia gravis. J. Med. Soc. Toho 43 (1997) 473-483
26. Shinomiya N., Nomura Y., and Segawa M. A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics. Clin. Immunol. 110 (2004) 154-158
27. Tzartos S. Current concepts on the structure of acetylcholine receptor with relevance to myasthenia gravis and autoimmune myasthenia gravis pathogenesis. In: Christadoss P. (Ed). Myasthenia Gravis: Disease Mechanisms and Immunointervention (2000), Narosa Publishing House, New Delhi 1-19
28. Vincent A., and Drachman D.B. Myasthenia Gravis. In: Pourmand R.Y., and Harati Y. (Eds). Advances in Neurology vol. 88 (2001), Lippincott Williams & Wilkins, Philadelphia, PA 159-188
29. Xu B.Y., Giscombe R., Sodrlund A., Troye-Blomberg M., Pirskanen R., and Lefvert A.K. Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations. Clin. Exp. Immunol. 113 (1998) 456-464